<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">16715587</article-id>
      <article-id pub-id-type="pmc">3294680</article-id>
      <article-id pub-id-type="publisher-id">05-0264</article-id>
      <article-id pub-id-type="doi">10.3201/eid1204.050264</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pulmonary Tuberculosis and SARS, China</article-title>
        <alt-title alt-title-type="running-head">Pulmonary Tuberculosis and SARS, China</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Wei</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fontanet</surname>
            <given-names>Arnaud</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Pan-He</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhan</surname>
            <given-names>Lin</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xin</surname>
            <given-names>Zhong-Tao</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>Fang</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baril</surname>
            <given-names>Laurence</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Cao</surname>
            <given-names>Wu-Chun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <aff id="aff1"><label>*</label>Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China, </aff>
        <aff id="aff2"><label>&#x2020;</label>Institut Pasteur, Paris, France;</aff>
        <aff id="aff3"><label>&#x2021;</label>Beijing Institute of Basic Medical Sciences, Beijing, People's Republic of China</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Wu-Chun Cao, Beijing Institute of Microbiology and Epidemiology, State Key Laboratory of Pathogen and Biosecurity, Beijing, People&#x2019;s Republic of China; fax: 86-10-6389-6082; email: <email xlink:href="caowc@nic.bmi.ac.cn">caowc@nic.bmi.ac.cn</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2006</year>
      </pub-date>
      <volume>12</volume>
      <issue>4</issue>
      <fpage seq="a">707</fpage>
      <lpage>709</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>SARS</kwd>
        <kwd>People&#x2019;s Republic of China</kwd>
        <kwd>pulmonary tuberculosis</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> As part of a cohort study of 83 patients with severe acute respiratory syndrome (SARS) in Beijing, China, we conducted a follow-up study of all the patients by routine medical examination. During the process, 3 patients with chest radiographs consistent with active disease were identified as having pulmonary tuberculosis (TB). Here we describe the 1-year clinical outcome and immune response in these patients.</p>
    <p>Demographic details and coexisting conditions are shown in the <xref ref-type="table" rid="T1">Table</xref>. Patient 1 was a healthcare worker who became infected with SARS-associated coronavirus (CoV) while on duty with SARS patients. After he was transferred to a hospital dedicated to SARS management, pulmonary TB was diagnosed (positive acid-fast bacilli smear on sputum samples). Patients 2 and 3 were known to have cases of pulmonary TB and became infected with SARS-CoV after contact with other patients hospitalized for SARS. These 2 patients were sputum smear&#x2013;negative for acid-fast bacilli, and diagnosis was made on the basis of previous exposure to TB, relevant symptoms of typical pulmonary TB, chest radiographs consistent with active disease, a positive tuberculin skin test result, and the finding of cavity regression on chest radiographs after anti-TB treatment was initiated. No cultures were obtained for isolation and comparison of <italic>Mycobacterium tuberculosis</italic> strains (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). All 3 patients had confirmed SARS based on amplification of SARS-CoV RNA by reverse transcriptase&#x2013;polymerase chain reaction (RT-PCR) from sputum and stool specimens (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Patients 2 and 3 recovered without complications; patient 1 had the most severe disease and required mechanical ventilation in an intensive care unit before recovering.</p>
    <table-wrap id="T1" position="float">
      <label>Table</label>
      <caption>
        <title>Demographic and clinical information on severe acute respiratory syndrome (SARS) patients with pulmonary tuberculosis (TB), Beijing, China, 2003</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="179" span="1"/>
        <col width="125" span="1"/>
        <col width="46" span="1"/>
        <col width="42" span="1"/>
        <thead>
          <tr>
            <th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Demographic/clinical characteristic</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Patient 1</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Patient 2</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Patient 3</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sex</td>
            <td valign="top" align="center" rowspan="1" colspan="1">M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">M</td>
            <td valign="top" align="center" rowspan="1" colspan="1">M</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age (y)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">48</td>
            <td valign="top" align="center" rowspan="1" colspan="1">18</td>
            <td valign="top" align="center" rowspan="1" colspan="1">20</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Other coexisting conditions</td>
            <td valign="top" align="center" rowspan="1" colspan="1"><italic>Pseudomonas aeruginosa</italic> infection</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
            <td valign="top" align="center" rowspan="1" colspan="1">None</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Date of SARS onset</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Apr 5, 2003</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Apr 7, 2003</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Apr 4, 2003</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Date of TB diagnosis</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Jun 12, 2003</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Jan 24, 2003</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Mar 5, 2003</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Date of hospitalization or transfer to SARS ward</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Apr 7, 2003</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Apr 7, 2003</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Apr 5, 2003</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Leukocyte count at admission, /&#x3BC;L</td>
            <td valign="top" align="center" rowspan="1" colspan="1">12,500</td>
            <td valign="top" align="center" rowspan="1" colspan="1">6,800</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2,500</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total steroid dose used, mg</td>
            <td valign="top" align="center" rowspan="1" colspan="1">25,280</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2,600</td>
            <td valign="top" align="center" rowspan="1" colspan="1">3,600</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Intensive care unit admission</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Yes</td>
            <td valign="top" align="center" rowspan="1" colspan="1">No</td>
            <td valign="top" align="center" rowspan="1" colspan="1">No</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">CD4/CD8 cell ratio 6 mo after disease</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.63</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1.56</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1.23</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Absolute CD4 cell count 6 mo after disease, /&#x3BC;L</td>
            <td valign="top" align="center" rowspan="1" colspan="1">368</td>
            <td valign="top" align="center" rowspan="1" colspan="1">431</td>
            <td valign="top" align="center" rowspan="1" colspan="1">306</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Absolute lymphocyte count 6 mo after disease, /&#x3BC;L</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2,098</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1,115</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1,666</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <p>Both cellular and humoral immunity were evaluated during the follow-up of these patients. T-lymphocyte subsets were measured 6 months after disease onset by flow cytometry using fluorescein isothiocyanate&#x2013;labeled specific monoclonal antibodies. Compared to other SARS patients (n = 47), the 3 patients with TB had lower mean CD4+ T cells (368.4/&#x3BC;L vs. 656.6/&#x3BC;L, respectively; p = 0.05) and lower mean CD8+ T cells (371.0/&#x3BC;L vs. 490.1/&#x3BC;L, respectively; p = 0.39). SARS-CoV immunoglobulin G (IgG) antibody titers were measured by enzyme-linked immunosorbent assay kit (Huada Company, Beijing, China) at months 1, 2, 3, 4, 7, 10, and 16 after disease onset. (Titers were not measured for the 3 TB patients at month l.) Compared to most (26 [78.8%] of 33) other SARS patients whose antibodies remained detectable throughout follow-up, 2 of the 3 TB patients (patients 1 and 3) had undetectable antibody titers as of months 7 and 16, respectively. In patient 1, antibody titers, when detectable, were unusually low (40). Both patients 1 and 3 had prolonged viral excretion in stools, sputum, or both. While the median (range) duration of virus excretion in stools and sputa for the entire measurable cohort (n = 56) was 27 (16&#x2013;127) and 21 (14&#x2013;52) days, respectively (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>), it was 125 and 16 days for patient 1, and 109 and 52 days for patient 3 (viral excretion data could not be obtained from patient 2 because sequential specimens for detection were unavailable).</p>
    <p>TB in SARS patients has been reported on rare occasions (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). In a cohort of 236 patients in Singapore, it was diagnosed in 2 patients after recovery from SARS (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). As with patient 1 in this study, TB had developed after the patient acquired SARS, most likely as the result of reactivation of past infection or new infection with <italic>M. tuberculosis</italic>, while temporarily immunosuppressed because of SARS (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>) and corticoid therapy. Such phenomena have been described with other viral infections such as measles and HIV (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). By contrast, patients 2 and 3 were known TB patients who acquired SARS through exposure to SARS patients in the same hospital wards. Both diseases are known to be transiently immunosuppressive (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R9"><italic>9</italic></xref>), and their combined effect resulted in more pronounced CD4+ cell decreases in coinfected SARS patients than others. Such immunosuppression also resulted in poorer IgG antibody response in coinfected SARS patients than in others and delayed viral clearance, as shown by longer viral excretion in sputum and stools. While viral excretion could be prolonged in coinfected patients, no virus could be isolated from any RT-PCR&#x2013;positive specimen collected after 6 weeks of illness, which suggests that excreted viruses were no longer infectious (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>).</p>
    <p>These case reports remind us of the importance of strict isolation of SARS patients, careful use of steroids for their case management, and the possibility of coinfection with TB in SARS patients with incomplete recovery.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Liu W, Fontanet A, Zhang P-H, Zhan L, Xin Z-T, Tang F, et al. Pulmonary tuberculosis and SARS, China [letter]. Emerg Infect Dis [serial on the Internet]. 2006 Apr [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1204.050264">http://dx.doi.org/10.3201/eid1204.050264</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <p>This work was partly supported by the Programme de Recherche en R&#xE9;seaux Franco-Chinois (P2R), the EC grant EPISARS (SP22-CT-2004-511063, SP22-CT-2004-003824), the National Institutes of Health CIPRA Project (NIH U19 AI51915), and the National 863 Program of China (2003AA208406, 2003AA208412C).</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Crawford</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Braden</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Schable</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Onorato</surname>
<given-names>ID</given-names></string-name>
<article-title>National Tuberculosis Genotyping and Surveillance Network: design and methods.</article-title>
<source>Emerg Infect Dis</source>. <year>2002</year>;<volume>8</volume>:<fpage>1192</fpage>&#x2013;<lpage>6</lpage><pub-id pub-id-type="pmid">12453342</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>
<article-title>Revised U.S. surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases&#x2014;United States and worldwide, December 2003.</article-title>
<source>MMWR Morb Mortal Wkly Rep</source>. <year>2003</year>;<volume>52</volume>:<fpage>1202</fpage>&#x2013;<lpage>6</lpage><pub-id pub-id-type="pmid">14668711</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Fontanet</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zhan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>QM</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>PH</given-names></string-name>, <etal/>
<article-title>Long-term SARS-coronavirus excretion from a patient cohort in China.</article-title>
<source>Emerg Infect Dis</source>. <year>2004</year>;<volume>10</volume>:<fpage>1841</fpage>&#x2013;<lpage>3</lpage><pub-id pub-id-type="pmid">15504274</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Low</surname>
<given-names>JGH</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Leo</surname>
<given-names>YS</given-names></string-name>
<article-title>Severe acute respiratory syndrome and pulmonary tuberculosis.</article-title>
<source>Clin Infect Dis</source>. <year>2004</year>;<volume>38</volume>:<fpage>e123</fpage>&#x2013;<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1086/421396</pub-id><pub-id pub-id-type="pmid">15227635</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>
<article-title>Nosocomial transmission of <italic>Mycobacterium tuberculosis</italic> found through screening for severe acute respiratory syndrome&#x2014;Taipei, Taiwan, 2003.</article-title>
<source>MMWR Morb Mortal Wkly Rep</source>. <year>2004</year>;<volume>53</volume>:<fpage>321</fpage>&#x2013;<lpage>2</lpage><pub-id pub-id-type="pmid">15103296</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Qiu</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>He</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>Z</given-names></string-name>, <etal/>
<article-title>Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome.</article-title>
<source>J Infect Dis</source>. <year>2004</year>;<volume>189</volume>:<fpage>648</fpage>&#x2013;<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1086/381535</pub-id><pub-id pub-id-type="pmid">14767818</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="book"><string-name><surname>Griffin</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>Bellini</surname>
<given-names>WJ</given-names></string-name> Measles. In: Fields BN, editor. Virology. New York: Raven Press; <year>1996</year> p. 1267&#x2013;312.</mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Havlir</surname>
<given-names>DV</given-names></string-name>, <string-name><surname>Barnes</surname>
<given-names>PF</given-names></string-name>
<article-title>Current concepts: tuberculosis in patients with human immunodeficiency virus infection.</article-title>
<source>N Engl J Med</source>. <year>1999</year>;<volume>340</volume>:<fpage>367</fpage>&#x2013;<lpage>73</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199902043400507</pub-id><pub-id pub-id-type="pmid">9929528</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Frieden</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Sterling</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Munsiff</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Watt</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Dye</surname>
<given-names>C</given-names></string-name>
<article-title>Tuberculosis.</article-title>
<source>Lancet</source>. <year>2003</year>;<volume>362</volume>:<fpage>887</fpage>&#x2013;<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(03)14333-4</pub-id><pub-id pub-id-type="pmid">13678977</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
